Experts: FDA, CMS Need Resources, Culture Shift To Collab On RWE

By David Roza / September 26, 2019 at 11:35 AM
Health care policy experts say FDA and CMS need new staff, training and resources from Congress in order to collaborate on real-world evidence that could be used simultaneously for regulatory evaluation and new payment models. They also say a broad culture shift is needed in how the agencies think about and use medical product data -- a shift they say could take years to fully achieve even though FDA and CMS leaders appear open to working together on RWE. The...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.